NUUBO develops textile medical electronics and wireless sensors for cardiac monitoring, including a system that records ECG to detect and diagnose irregular heart rhythms and help prevent cardiovascular events. The company was founded in 2005 and has offices in Paterna and Madrid. NUUBO’s monitoring system is positioned toward clinical detection of arrhythmias and cardiovascular risk prevention. The company closed a €270,000 financing intended to support its expansion into the United States. The financing was led by a health-focused coinvestment vehicle, reflecting investor interest from public and private backers. No operating metrics were disclosed in the article. Nuubo designs, manufactures and sells a proprietary wearable wireless ECG system comprised of a comfortable textile Holter (no adhesives, no wires) and arrhythmia analysis software. The CE-marked system offers up to 60 days of cardiac monitoring and has demonstrated over 20% diagnostic yield for atrial fibrillation in cryptogenic stroke during a 30-day monitoring period. The product fills a gap between short-term non-invasive monitors (7–14 days) and long-term invasive implants, targeting improved detection of arrhythmias such as atrial fibrillation. Nuubo holds several patents in the EU and USA and is certified to ISO 27001, ISO 13485 and ISO 9001. The company is headquartered in Madrid with R&D and manufacturing facilities in Valencia, Spain, and is supported by Spanish VCs including Cross Roads Biotech Inverbio, Caixa and Fides Capital. The announced financing is intended to accelerate growth, expand commercial presence in Europe and the US, and fund clinical trials and new product development. Nuubo develops biomedical garments and a platform that simplify heart monitoring by enabling continuous, cable-free electrocardiogram (ECG) readings in dynamic environments. Its platform, the nECG DYNAMIC PLATFORM, allows users to perform and read ECGs remotely. The company says its solution removes the need for cables, requiring only a piece of clothing to monitor cardiac activity. Nuubo started commercial activities in 2012 and has a production centre in Paterna (Valencia) and 22 employees in Madrid. It intends to use the new funds to position itself in the main European markets. The company expects to exceed €1m in sales in 2014.

Total raised

$10M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2022